Alessi-SeveriniS, BiscontriRG, CollinsDM, SareenJ, EnnsMW. Ten years of antipsychotic prescribing to children: A Canadian population-based study. Can J Psychiatry, 57:52–58. 2012.
2.
BladerJC. Pharmacotherapy and postdischarge outcomes of child inpatients admitted for aggressive behavior. J Clin Psychopharmacol, 26:419–425. 2006.
3.
BladerJC, PliszkaSR, JensenPS, SchoolerNR, KafantarisV. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics, 126:e796–806. 2010.
4.
Breland–NobleAM, ElbogenEB, FarmerEM, DubsMS, WagnerHR, BurnsBJ. Use of psychotropic medications by youths in therapeutic foster care and group homes. Psychiatr Serv, 55:706–708. 2004.
5.
CarlsonGA. Who are the children with severe mood dysregulation, a.k.a. “rages”?Am J Psychiatry, 164:1140–1142. 2007.
6.
CarlsonGA, KellyKL. Stimulant rebound: How common is it and what does it mean?J Child Adolesc Psychopharmacol, 13:137–142. 2003.
CarlsonGA, PotegalM, MarguliesD, BasileJ, GutkovichZ. Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder. Bipolar Disord, 12:205–212. 2010.
9.
CarlsonGA, PotegalM, MarguliesD, GutkovichZ, BasileJ. Rages—what are they and who has them?J Child Adolesc Psychopharmacol, 19:281–288. 2009.
10.
CarlsonGA, YoungstromEA. Clinical implications of pervasive manic symptoms in children. Biol Psychiatry, 53:1050–1058. 2003.
11.
ConnorDF, CarlsonGA, ChangKD, DaniolosPT, FerzigerR, FindlingRL, HutchinsonJG, MaloneRP, HalperinJM, PlattnerB, PostRM, ReynoldsDL, RogersKM, SaxenaK, SteinerH. Juvenile maladaptive aggression: A review of prevention, treatment, and service configuration and a proposed research agenda. J Clin Psychiatry, 67:808–820. 2006.
12.
ConnorDF, GlattSJ, LopezID, JacksonD, MelloniRHJr. Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry, 41:253–261. 2002.
13.
FindlingRL, NyilasM, ForbesRA, McQuadeRD, JinN, IwamotoT, IvanovaS, CarsonWH, ChangK. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: A randomized, double-blind, placebo-controlled study. J Clin Psychiatry, 70:1441–1451. 2009.
MarguliesDM, WeintraubS, BasileJ, GroverPJ, CarlsonGA. Will disruptive mood dysregulation disorder reduce false diagnosis of bipolar disorder in children?Bipolar Disord, 14:488–496. 2012.
16.
McLaughlinKA, GreenJG, HwangI, SampsonNA, ZaslavskyAM, KesslerRC. Intermittent explosive disorder in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry, 2:1–9. 2012.
17.
OlfsonM, BlancoC, LiuL, MorenoC, LajeG. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry, 63:679–685. 2006.
18.
OlfsonM, BlancoC, LiuSM, WangS, CorrellCU. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry, 6:1–10. 2012.
19.
OrvaschelH, Puig–AntichJ, ChambersW, TabriziMA, JohnsonR. Retrospective assessment of prepubertal major depression with the KIDDIE-SADS-E. J Am Acad Child Psychiatry, 21:392–397. 1982.
20.
PappadopulosE, WoolstonS, ChaitA, PerkinsM, ConnorDF, JensenPS. Pharmacotherapy of aggression in children and adolescents: Efficacy and effect size. J Can Acad Child Adolesc Psychiatry, 15:27–39. 2006.
21.
PatelNC, CrismonML, HoagwoodK, JohnsrudMT, RascatiKL, WilsonJP, JensenPS. Trends in the use of typical and atypical antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry., 44:548–556. 2005.
22.
PliszkaSR, CrismonML, HughesCW, CornersCK, EmslieGJ, JensenPS, McCrackenJT, SwansonJM, LopezM. Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder. The Texas Children's Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry, 45:642–657. 2006.
23.
RaniF, MurrayML, ByrnePJ, WongIC. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics, 121:1002–1009. 2008.
24.
ReinbergS. More kids taking antipsychotics for ADHD: Study. Health Day Reporter, August7, 2012.
25.
TohenM, KryzhanovskayaL, CarlsonG, DelbelloM, WozniakJ, KowatchR, WagnerK, FindlingR, LinD, Robertson–PlouchC, XuW, DittmannRW, BiedermanJ. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry, 164:1547–1556. 2007.
